Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Inventory (2016 - 2025)

Surgery Partners (SGRY) has disclosed Inventory for 12 consecutive years, with $96.6 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 9.28% to $96.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $96.6 million through Dec 2025, up 9.28% year-over-year, with the annual reading at $96.6 million for FY2025, 9.28% up from the prior year.
  • Inventory hit $96.6 million in Q4 2025 for Surgery Partners, up from $92.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $96.6 million in Q4 2025 to a low of $56.1 million in Q1 2021.
  • Historically, Inventory has averaged $74.0 million across 5 years, with a median of $71.6 million in 2022.
  • Biggest five-year swings in Inventory: rose 1.17% in 2023 and later increased 18.16% in 2024.
  • Year by year, Inventory stood at $61.1 million in 2021, then grew by 16.86% to $71.4 million in 2022, then grew by 5.32% to $75.2 million in 2023, then increased by 17.55% to $88.4 million in 2024, then increased by 9.28% to $96.6 million in 2025.
  • Business Quant data shows Inventory for SGRY at $96.6 million in Q4 2025, $92.3 million in Q3 2025, and $87.3 million in Q2 2025.